NCT06463808View on ClinicalTrials.gov

Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2025

Conditions

Ventricular RemodelingMyocardial Infarction, Anterior Wall

Interventions

DRUG

Recombinant Human Brain Natriuretic Peptide

we divide our subjects into two groups;one is required to take recombinant human brain natriuretic peptide,the other is not required to take recombinant human brain natriuretic peptide

Trial Locations (1)

Unknown

RECRUITING

the First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER